Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Tandem synthesis of dihydronaphthalen-1(2H)-one derivatives via aldol condensation-Diels–Alder-aromatization sequence of reactions

M. Saeed Abaee*a, Yazdanbakhsh L. Nosoodb, Elaheh Akbarzadeha, Mohammad M. Mojtahedia and Ahmed Al-Harrasib
aOrganic Chemistry Department, Chemistry and Chemical Engineering Research Center of Iran, P.O. Box 14335-186, Tehran, Iran. E-mail: abaee@ccerci.ac.ir
bNatural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Postal Code 616, Birkat Al Mauz, Nizwa, Sultanate of Oman

Received 1st July 2025 , Accepted 25th August 2025

First published on 4th September 2025


Abstract

A new series of dihydronaphthalen-1(2H)-one derivatives were synthesized in high yields starting from commercially available 3,5,5-trimethylcyclohex-2-en-1-one 1a, aromatic aldehydes 2, and diethyl acetylenedicarboxylate. Reaction of 1a with the aldehydes produced the respective dienones 3, which could cycloadd to dialkyl acetylenedicarboxylate, either stepwise or in situ, under aqueous/organocatalyzed (DMAP) conditions. The respective adducts 4, were produced efficiently via a Diels–Alder-double bond isomerization-oxidative aromatization sequence and were characterized based on the analysis of their 1H and 13C NMR spectra.


Introduction

4-Dimethylaminopyridine (DMAP) is an amine with improved basicity1 and nucleophilicity,2 suitable to accelerate various organic transformations conveniently.3 As a catalyst, DMAP is used in the synthesis of α,β-unsaturated δ-lactones,4 Buchwald–Hartwig C–N coupling,5 N-vinylation,6 [4 + 2] cycloadditions,7 and many other synthetic reactions.8 DMAP is also conveniently used in domino carbonylation-electrocyclization synthesis of imidazodipyridines9 and cascade synthesis of α-pyrones.10 In addition to usual homogeneous uses, DMAP can be used in the form of ionic liquids11 or immobilized derivatives.12 The advantages of DMAP in organic chemistry are not limited to its regular basic or nucleophilic properties and are additionally highlighted due to its uses in biological,13 medicinal,14,15 and nanoparticle disciplines,16 while DMAP has shown several applications in chiral catalysis17 and asymmetric synthesis18 and has got involved in synthetic protocols as a reactant19 or the active part of starting materials.20 Some illustrative cases are highlighted in Fig. 1.
image file: d5ra04673d-f1.tif
Fig. 1 Some important synthetic roles of DMAP.

Cyclohexenone derivatives are a group of usually inexpensive commercially available reactants for various convenient transformations to more complex products,21–23 including the aromatization process to their respective phenol equivalents.24 Among this group of compounds, the 3-methyl substituted derivative 1 would be a suitable candidate for both aromatization to the respective phenol and chain extension via aldol condensation with aldehydes25 or coupling reactions with vinylogous species26 at the allylic methyl position. The resulting dienes have the advantages for further synthetic manipulations through cycloaddition reactions with acetylenic dienophiles to access the respective polysubstituted dihydronaphthalen-1-one (A) or naphthol analogues (B), which in turn are useful synthons to access natural27,28 or synthetic29 structures (Fig. 2).


image file: d5ra04673d-f2.tif
Fig. 2 3-Methylcyclohexenone route to aromatic DA adducts.

The [4 + 2] Diels–Alder (DA) cycloaddition is a key reaction in synthetic organic chemistry,30 due to efficient formation of a cyclohexene ring with up to four stereogenic centres with predictable selectivity.31 Incorporation of this reaction with other important organic transformations into tandem processes multiplies the efficiency of the DA cycloaddition so that many synthetic applications have arisen in recent decades as a result of DA-Hantzsch,32 Biginelli-DA,33 Heck-DA,34 Knoevenagel-DA,35 aldol condensation-DA,36 and other sequential reactions.37,38

We are interested in the study of DA reactions and have communicated our findings on the synthesis and cycloaddition reactions of the styrylcyclohexene diene system in recent years.39,40 Based on this background, we were persuaded to extend our study to embark on direct synthesis of the dihydronaphthalen skeleton starting from 3,5,5-trimethylcyclohex-2-en-1-one (1a, isophorone). We hereby disclose the synthesis of various derivatives of 4 through a tandem aldol-condensation-Diels–Alder-rearrangement-aromatization sequence of reactions under aqueous/DMAP conditions, as depicted in Scheme 1 for the reaction of 1a with benzaldehyde and the following cycloaddition step of 3a with diethyl acetylenedicarboxylate (DEAD).


image file: d5ra04673d-s1.tif
Scheme 1 Typical stepwise reaction pathway for the conversion of 1 to 3 and 3 to 4.

Results and discussion

We first optimized the conditions for both steps. While a mixture of 1a and benzaldehyde 2a in aqueous DMAP gave low quantities of 3a at room temperature (entry 1), treatment of the same mixture at 60 °C produced 84% of the product after 3 h (entry 2). In contrast, the yield diminished in the absence of either DMAP (entry 3) or water (entry 4). This was also the case when water was replaced with an alcohol (entries 5–6), toluene (entry 7), MeCN (entry 8), or THF (entry 9) as the medium of the reaction.41 Alternatively, separation of 3a and its treatment with DEAD in the same H2O/DMAP medium gave 4a in much higher quantities at reflux (entry 10).42 Treatment of the same mixture at lower temperatures was less productive (entries 11 and 12) (Table 1).
Table 1 Three-component optimization of the synthesis of 3a
Entry Reactants Conditionsa Temperature (oC) Time (h) Product Yieldb (%)
a 10 mol% DMAP was used in all reactions.b Isolated yields.
1 1a + 2a DMAP, H2O rt 3 3a 17
2 1a + 2a DMAP, H2O 60 3 3a 84
3 1a + 2a H2O 60 3 3a >5
4 1a + 2a DMAP 60 3 3a 24
5 1a + 2a DMAP, EtOH 60 3 3a 10
6 1a + 2a DMAP, MeOH 60 3 3a 12
7 1a + 2a DMAP, toluene 60 3 3a >5
8 1a + 2a DMAP, MeCN 60 3 3a 12
9 1a + 2a DMAP, THF 60 3 3a >5
10 3a + DEAD DMAP, H2O 100 48 4a 81
11 3a + DEAD DMAP, H2O 80 48 4a 38
12 3a + DEAD DMAP, H2O 60 48 4a 22


Having the two sets of optimized conditions, we next evaluated the generality of the method by using other derivatives of 2 (Table 2). Thus, in addition to unsubstituted aromatic aldehydes (entries 1 and 2), the H2O/DMAP mediated condensation of various aldehydes bearing electron releasing (entries 3 and 4) or electron withdrawing (entries 5–11) and heteroaromatic groups (entry 12) with 1a gave the respective aldol condensation products in high yields. Alternatively, isolation of 3a–l and their separate treatment with DEAD (entries 14–18 and 20–25) or dimethyl acetylenedicarboxylate (DMAD) (entries 13 and 19) in the same aqueous DMAP mixtures yielded 4a–l efficiently.

Table 2 Stepwise synthesis of various derivatives of 3 and 4
Entry Conditionsa Reactants Ar Product Yieldbb (%)
a 10 mol% DMAP was used in all reactions.b Isolated yields.
1 DMAP, H2O, 60 °C 1a + 2a C6H5 3a 84
2 DMAP, H2O, 60 °C 1a + 2b 2-Naphthyl 3b 84
3 DMAP, H2O, 60 °C 1a + 2c 4-MeC6H4 3c 81
4 DMAP, H2O, 60 °C 1a + 2d 4-MeOC6H4 3d 87
5 DMAP, H2O, 60 °C 1a + 2e 3-MeOC6H4 3e 78
6 DMAP, H2O, 60 °C 1a + 2f 4-FC6H4 3f 82
7 DMAP, H2O, 60 °C 1a + 2g 4-BrC6H4 3g 80
8 DMAP, H2O, 60 °C 1a + 2h 4-CF3C6H4 3h 81
9 DMAP, H2O, 60 °C 1a + 2i 3-O2NC6H4 3i 80
10 DMAP, H2O, 60 °C 1a + 2j 4-ClC6H4 3j 83
11 DMAP, H2O, 60 °C 1a + 2k 2,6-Cl2C6H3 3k 75
12 DMAP, H2O, 60 °C 1a + 2l 2-Thienyl 3l 79
13 DMAP, H2O, reflux 3a + DMAD C6H5 4a 85
14 DMAP, H2O, reflux 3a + DEAD C6H5 4a′ 83
15 DMAP, H2O, reflux 3b + DEAD 2-Naphthyl 4b 78
16 DMAP, H2O, reflux 3c + DEAD 4-MeC6H4 4c 83
17 DMAP, H2O, reflux 3d + DEAD 4-MeOC6H4 4d 86
18 DMAP, H2O, reflux 3e + DEAD 3-MeOC6H4 4e 77
19 DMAP, H2O, reflux 3f + DMAD 4-FC6H4 4f 81
20 DMAP, H2O, reflux 3g + DEAD 4-BrC6H4 4g 78
21 DMAP, H2O, reflux 3h + DEAD 4-CF3C6H4 4h 82
22 DMAP, H2O, reflux 3i + DEAD 3-O2NC6H4 4i 80
23 DMAP, H2O, reflux 3j + DEAD 4-ClC6H4 4j 81
24 DMAP, H2O, reflux 3k + DEAD 2,6-Cl2C6H3 4k 75
25 DMAP, H2O, reflux 3l + DEAD 2-Thienyl 4l 80


We then evaluated the feasibility of conducting both steps in a one-pot procedure (Table 3). For this, we examined the conditions for the reaction of 1a with benzaldehyde and DEAD in a water/DMAP mixture, where initial warming of the mixture of 1a and 2a to 60 °C (1 h) and delayed addition of the dienophile DMAD to the mixture and switching the conditions to refluxing temperature produced 4a in 82% yield within 48 h (entry 1). Successful reactions of other aldehydes with either DMAD or DEAD illustrated the generality of the process by producing their respective adducts in high yields (entries 2–13).

Table 3 One-pot synthesis of derivatives of 4

image file: d5ra04673d-u1.tif

Entry Reactantsa Ar R Product Yieldb (%)
a 10 mol% DMAP was used in all reactions.b Isolated yields.
1 1a + 2a + DMAD C6H5 Me 4a 82
2 1a + 2a + DEAD C6H5 Et 4a′ 80
3 1a + 2b + DEAD 2-Naphthyl Et 4b 80
4 1a + 2c + DEAD 4-MeC6H4 Et 4c 77
5 1a + 2d + DEAD 4-MeOC6H4 Et 4d 78
6 1a + 2e + DEAD 3-MeOC6H4 Et 4e 80
7 1a + 2a + DMAD 4-FC6H4 Me 4f 86
8 1a + 2f + DEAD 4-BrC6H4 Et 4g 80
9 1a + 2g + DEAD 4-CF3C6H4 Et 4h 80
10 1a + 2a + DMAD 3-O2NC6H4 Et 4i 75
11 1a + 2a + DMAD 4-ClC6H4 Et 4j 85
12 1a + 2a + DMAD 2,6-Cl2C6H3 Et 4k 81
13 1a + 2a + DMAD 2-Thienyl Et 4l 80


Based on the results obtained here and in view of the basicity of DMAP as an organocatalyst in aqueous media,43 a mechanism was proposed for the one-pot combination of the reactants, as shown in Fig. 3 for the reaction of benzaldehyde with 1a and DEAD. Primarily, the DMAP preferably removed the γ acidic proton (Me group) to give the dienolate intermediate (1a′). In continuation, the intermediate attacked the aldehyde to complete the aldol step, giving 3a′ and then 3a. Cycloaddition of 3a with DEAD followed by in situ aromatization of 4a′′ produced the final product 4a′.44


image file: d5ra04673d-f3.tif
Fig. 3 The proposed mechanism.

Experimental

General

All reagents were commercially available and used as received. Progress of the reactions was monitored by TLC using silica gel coated plates and EtOAc/petroleum ether mixture as the eluent. Melting points are uncorrected and obtained by Buchi Melting Point 530 apparatus. 1H NMR (300 MHz or 600 MHz) and 13C NMR (75 MHz or 150 MHz) spectra are obtained on a FT-NMR Bruker Ultra Shield™ (or Bruker DRX-600) instrument as CDCl3 solutions, and the chemical shifts are expressed as δ units with Me4Si as the internal standard. Chemical ionization (CI) HRMS data are obtained (with MeOH as the ionization source) using Agilent technologies 6530 Q-TOF-LC-MS. The identity of the known products was confirmed by the comparison of their 1H NMR and 13C NMR spectra with those of authentic compounds reported in the literature.45,46 All new products were fully characterized based on their spectral data.

Typical synthesis of 3a

A mixture of 1a (300 μL, 2.0 mmol), benzaldehyde 2a (284 μL, 2.0 mmol), and DMAP (25 mg, 10 mol%) in water (1.0 mL) was stirred at 60 °C for 3 h. After completion of the reaction (monitored by TLC using EtOAc/hexanes (1[thin space (1/6-em)]:[thin space (1/6-em)]4) as the eluent), the mixture was extracted with EtOAc (3 × 5 mL), washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure. Product 3a (380 mg, 84%) was obtained by column chromatography fractionation of the residue using (EtOAc/hexanes, 1[thin space (1/6-em)]:[thin space (1/6-em)]4, v/v).

Typical stepwise synthesis of 4a′

A mixture of 3a (1.0 mmol, 226 mg) and DEAD (255 mg, 1.5 mmol), and DMAP (13 mg, 10 mol%) in H2O (2.0 mL) was refluxed for 48 h, until TLC showed completion of the process. The product was extracted from the reaction mixture with EtOAc (5.0 mL), washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure. Product 4a′ (327 mg, 83%) was obtained by column chromatography fractionation of the residue using (EtOAc/hexanes, 1[thin space (1/6-em)]:[thin space (1/6-em)]4, v/v).

Typical one-pot synthesis of 4a′

A mixture of 1a (150 μL, 1.0 mmol), benzaldehyde 2a (142 μL, 1.0 mmol), and DMAP (13 mg, 10 mol%) in water (1.0 mL) was stirred at 60 °C for 3 h. At this point, DEAD (255 mg, 1.5 mmol) was added to the mixture and the mixture was refluxed for another 36 h. The product was extracted from the reaction mixture with EtOAc (5.0 mL), washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure. Product 4a′ (316 mg, 80%) was obtained by column chromatography fractionation of the residue using (EtOAc/hexanes, 1[thin space (1/6-em)]:[thin space (1/6-em)]4, v/v).

Spectral data of new products

(E)-5,5-dimethyl-3-(4-(trifluoromethyl)styryl)cyclohex-2-en-1-one 3h. Mp 103–105 °C; IR (KBr): 1324, 1586, 2161, 1655, 2933, 9961 cm−1; 1H NMR (300 MHz, CDCl3) δ 1.12 (s, 6H), 2.33 (s, 2H), 2.49 (s, 2H), 6.12 (s, 1H), 6.99 (s, 2H), 7.59 (d, J = 8.0 Hz, 2H), 7.63 (d, J = 8.0 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 28.4, 33.3, 38.9, 51.3, 125.7 (q, J = 28 Hz), 127.2, 128.2, 130.3, 130.7, 131.9, 133.0, 139.4, 153.7, 200.1; MS (70 eV) m/z (%), 294 (M+), 142, 170, 262, 277; anal. calcd for C17H17F3O: C, 69.38; H, 5.82. Found: C, 69.20; H, 5.79.
(E)-3-(2,6-dichlorostyryl)-5,5-dimethylcyclohex-2-en-1-one 3k. Mp 69–71 °C; IR (KBr): 1587, 1616, 1657, 2930, 2947 cm−1; 1H NMR (300 MHz, CDCl3 δ) 1.12 (s, 6H), 2.32 (s, 2H), 2.50 (s, 2H), 6.06 (s, 1H), 6.94 (d, J = 16.5 Hz, 1H), 7.01 (d, J = 16.5 Hz, 1H), 7.13 (t, J = 8.0 Hz, 1H), 7.33 (d, J = 8.0 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 28.4, 33.2, 38.5, 51.3, 128.2, 128.4, 128.6, 128.9, 133.3, 134.4, 137.7, 153.7, 200.1; MS (70 eV) m/z (%), 294 (M+), 176, 204, 260; anal. calcd for C16H16Cl2O: C, 65.10; H, 5.46. Found: C, 64.87; H, 5.37.
Dimethyl 6,6-dimethyl-8-oxo-3-phenyl-5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate (4a). Mp 151–153 °C; IR (KBr): 2949, 1739, 1694, 1588 cm−1; 1H NMR (600 MHz, CDCl3): 1.03 (s, 6H), 2.58 (s, 2H), 2.93 (s, 2H), 3.62 (s, 3H), 3.97 (s, 3H), 7.22 (d, J = 8.0 Hz, 2H), 7.29 (s, 1H), 7.56 (d, J = 8.0 Hz, 2H); 13C NMR (150 MHz, CDCl3): 28.1, 33.7, 43.8, 52.5, 52.6, 53.0, 122.9, 128.5, 129.6, 129.7, 131.7, 132.0, 134.2, 138.2, 144.5, 145.4, 167.4, 169.0, 196.3; ESI-HRMS (MeOH) (m/z): calcd for [C22H22O5 + H]+: 367.1540, found: 367.1545.
Diethyl 7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-[2,2′-binaphthalene]-3,4-dicarboxylate (4b). Mp 124–125 °C; IR (KBr): 2969, 2255, 1726, 1241 cm−1; 1H NMR (600 MHz, CDCl3): 0.50 (t, J = 7.5 Hz, 3H), 1.14 (s, 3H), 1.17 (s, 3H), 1.41 (t, J = 7.5 Hz, 3H), 2.62 (q, J = 7.5 Hz, 2H), 2.96 (q, J = 7.5 Hz, 2H), 2.93 (s, 2H) 4.46 (q, J = 7.5 Hz, 2H), 7.34 (dd, J = 8.0 Hz, 1H), 7.36 (s, 1H); 7.45 (dd, J = 8.0, 8.0 Hz, 1H), 7.50 (dd, J = 8.0, 8.0 Hz, 2H), 7.59 (d, J = 8.0 Hz, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.91 (d, J = 8.0 Hz, 1H); 13C NMR (150 MHz, CDCl3): 13.0, 13.9, 28.0, 28.3, 33.8, 43.8, 52.7, 61.1, 61.9, 125.0, 125.7, 126.1, 126.3, 126.4, 128.2, 128.4, 128.7, 131.3, 131.5, 133.2, 133.3, 134.4, 137.4, 144.9, 145.0, 166.4, 168.7196.4; ESI-HRMS (MeOH) (m/z): calcd for [C28H28O5 + H]+: 445.2009, found: 445.2010.
Diethyl 3-(4-fluorophenyl)-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate (4f). Mp 93–95 °C; IR (KBr): 3062, 1729, 1233 cm−1; 1H NMR (600 MHz, CDCl3): 1.02 (t, J = 7.0 Hz, 3H). 1.11 (s, 6H), 1.40 (t, J = 7.0 Hz, 3H), 2.58 (s, 2H), 2.93 (s, 2H), 4.07 (q, J = 7.0 Hz, 2H), 4.44 (q, J = 7.0 Hz, 2H), 7.11–7.14 (m, 2H), 7.28 (s, 1H), 7.33–7.35 (m, 2H); 13C NMR (150 MHz, CDCl3): 13.6, 13.9, 28.1, 33.8, 43.8, 52.6, 61.8, 62.0, 115.5 (d, J = 21.0 Hz), 128.3, 128.8 (d, J = 9.0 Hz), 130.3, 131.9, 134.2, 135.5, 144.8 (d, J = 84.0 Hz), 144.4 (d, J = 247.5 Hz), 145.1 (d, J = 211.5 Hz), 196.3; ESI-HRMS (MeOH) (m/z): calcd for [C24H25FO5 + H]+: 413.1759, found: 413.1759.
Diethyl 3-(4-bromophenyl)-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate (4g). Mp 133–135 °C; IR (KBr): 2981, 1737, 1591 cm−1; 1H NMR (300 MHz, CDCl3): 0.94 (t, J = 7.0 Hz, 3H). 1.04 (s, 6H), 1.31 (t, J = 7.0 Hz, 3H), 2.49 (s, 2H), 2.84 (s, 2H), 4.00 (q, J = 7.0 Hz, 2H), 4.35 (q, J = 7.0 Hz, 2H), 7.14 (d, J = 7.5 Hz, 2H), 7.18 (s, 1H), 7.45 (d, J = 7.5 Hz, 2H); 13C NMR (75 MHz, CDCl3): 13.6, 13.9, 28.1, 33.8, 43.8, 52.6, 61.8, 62.0, 122.7, 128.5, 129.7, 130.1, 131.6, 131.7, 134.3, 138.4, 144.4, 145.1, 166.9, 167.4, 167.1, 196.2; ESI-HRMS (MeOH) (m/z): calcd for [C24H25BrO5 + H]+: 473.0958, found: 473.0964.
Diethyl 6,6-dimethyl-8-oxo-3-(4-(trifluoromethyl)phenyl)-5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate (4h). IR (KBr): 2971, 1728, 1592 cm−1; 1H NMR (300 MHz, CDCl3): 0.96 (t, J = 7.0 Hz, 3H). 1.12 (s, 6H), 1.40 (t, J = 7.0 Hz, 3H), 2.58 (s, 2H), 2.93 (s, 2H), 4.04 (q, J = 7.0 Hz, 2H), 4.44 (q, J = 7.0 Hz, 2H), 7.30 (s, 1H), 7.46 (d, J = 7.5 Hz, 2H), 7.69 (d, J = 7.5 Hz, 2H); 13C NMR (75 MHz, CDCl3): 13.2, 13.6, 27.8, 33.5, 43.6, 52.3, 61.5, 61.8, 122.0 (q, J = 28.0 Hz), 125.1, 128.2, 128.5, 129.8, 130.0, 130.4, 131.6, 134.2, 142.9, 143.8, 145.1, 167.1 (d, J = 125.0 Hz), 195.9; ESI-HRMS (MeOH) (m/z): calcd for [C25H25F3O5 + H]+: 463.1727, found: 463.1732.
Diethyl 6,6-dimethyl-3-(3-nitrophenyl)-8-oxo-5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate (4i). Mp 140–141 °C; IR (KBr): 2949, 1738, 1587, 1237 cm−1; 1H NMR (300 MHz, CDCl3): 1.03 (t, J = 7.0 Hz, 3H). 1.12 (s, 6H), 1.39 (t, J = 7.0 Hz, 3H), 2.58 (s, 2H), 2.94 (s, 2H), 4.08 (q, J = 7.0 Hz, 2H), 4.43 (q, J = 7.0 Hz, 2H), 7.32 (s, 1H), 7.60 (dd, J = 7.5, 7.5 Hz, 1H), 7.67 (dt, J = 1.5, 7.5 Hz, 1H), 8.20–8.30 (m, 2H); 13C NMR (75 MHz, CDCl3): 13.6, 13.9, 28.1, 33.8, 43.8, 52.5, 61.9, 62.1, 123.0, 123.1, 129.1, 129.4, 129.9, 132.0, 134.1, 134.6, 141.0, 142.9, 145.5, 148.1, 166.3, 168.1, 196.1; ESI-HRMS (MeOH) (m/z): calcd for [C24H25NO7 + H]+: 440.1704, found: 440.1709.
Diethyl 3-(2,6-dichlorophenyl)-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalene-1,2-dicarboxylate (4k). Mp 182–185 °C; IR (KBr): 2972, 1729, 1593 cm−1; 1H NMR (300 MHz, CDCl3): 0.95 (t, J = 7.0 Hz, 3H). 1.13 (s, 6H), 1.41 (t, J = 7.0 Hz, 3H), 2.60 (s, 2H), 2.94 (s, 2H), 4.05 (q, J = 7.0 Hz, 2H), 4.45 (q, J = 7.0 Hz, 2H), 7.16 (s, 1H), 7.28 (dd, J = 7.5, 7.5 Hz, 1H), 7.39 (dd, J = 1.5, 7.5 Hz, 2H); 13C NMR (75 MHz, CDCl3): 13.4, 13.9, 28.1, 33.8, 43.8, 52.7, 61.4, 61.9, 127.1, 129.2, 129.4, 129.5, 132.6, 134.1, 135.4, 138.0, 141.5, 145.9, 165.0, 168.5, 196.4; ESI-HRMS (MeOH) (m/z): calcd for [C24H24Cl2O5 + H]+: 463.1074, found: 463.1079.

Conclusions

In summary, we introduced a novel three-component method for the synthesis of a series of polysubstituted dihydronaphthalene derivatives. Both the diene formation and the cycloaddition steps were performed sequentially in the same pot using all three required reactants. The process was easy to operate by using an aqueous DMAP medium with no extra catalyst or additive needed. Additionally, a single product was obtained for each of the reactions in a good overall yield.

Author contributions

M. S. Abaee conceived and designed the work. Y. L. Nosood and E. Akbarzadeh performed the experiments and collected data. M. M. Mojtahedi reviewed the draft and performed the literature survey. A. Al-Harrasi conducted some of the analyses. All authors analyzed the data, discussed the results, and reviewed the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the SI. Supplementary information: Spectra of new compounds (1H NMR, 13C NMR). See DOI: https://doi.org/10.1039/d5ra04673d.

Acknowledgements

We would like to thank CCERCI for financial support of this work (Grant number 1402-102).

Notes and references

  1. H. J. Lee, T. T. Nguyen, A. V. Tran, H. S. Kim, Y.-W. Suh, J. Baek and Y. J. Kim, J. Ind. Eng. Chem., 2023, 123, 140–149 CrossRef .
  2. K. L. Jantzi, S. Wiltrakis, L. Wolf, A. Weber, J. Cardinal and K. Krieter, J. Chem. Educ., 2011, 88, 328–330 CrossRef CAS .
  3. C. Grondal, Synlett, 2003, 14, 1568–1569 CrossRef .
  4. J. Jin, Q. Xu and W. Deng, Chin. J. Chem., 2017, 35, 397–400 CrossRef CAS .
  5. S. Roy, M. M. Dutta, M. J. Sarma and P. Phukan, ChemistrySelect, 2019, 4, 13094–13098 CrossRef CAS .
  6. K. Mondal, S. Patra, P. Halder, N. Mukhopadhyay and P. Das, Org. Lett., 2023, 25, 1235–1240 CrossRef CAS PubMed .
  7. D. Li, J. Wu, L. Yang, S. Cai, Y. Tang, Y. Li and S. Xu, Org. Lett., 2025, 27, 51–56 CrossRef CAS PubMed .
  8. J. T. Myers, S. J. Dakermanji, T. R. Chastanet, P. J. Shivokevich, L. J. Strausberg, M. Sabat, W. H. Myers and W. D. Harman, Organometallics, 2017, 36, 543–555 CrossRef CAS .
  9. K. Zhang, A. El Bouakher, H. Lévaique, J. Bignon, P. Retailleau, M. Alami and A. Hamze, Adv. Synth. Catal., 2020, 362, 3243–3256 CrossRef CAS .
  10. A. Jain, A. Kumari, S. K. Saha, K. Shukla, A. Chauhan, R. K. Metre and N. K. Rana, J. Org. Chem., 2023, 88, 11346–11351 CrossRef CAS PubMed .
  11. S. A. Ghumro, S. Saleem, M. al-Rashida, N. Iqbal, R. D. Alharthy, S. Ahmed, S. T. Moin and A. Hameed, RSC Adv., 2017, 7, 34197–34207 RSC .
  12. V. D'Elia, Y. Liu and H. Zipse, Eur. J. Org Chem., 2011, 1527–1533 CrossRef .
  13. A. Anwar, S. Khalid, S. Perveen, S. Ahmed, R. Siddiqui, N. A. Khan and M. R. Shah, J. Nanobiotechnol., 2018, 16, 1–8 CrossRef PubMed .
  14. G. C. Lan, D. Han, Y. G. Wu, Z. B. Han, S. F. Ma, X. Y. Liu, C. L. Chang and J. H. Tan, Mol. Reprod. Dev., 2005, 71, 380–388 CrossRef CAS PubMed .
  15. R. Viveiros, J. J. Pinto, N. Costa, W. Heggie and T. Casimiro, J. Supercrit. Fluids, 2023, 194, 105853–105858 CrossRef CAS .
  16. J. P. Vivek and I. J. Burgess, J. Phys. Chem. C, 2008, 112, 2872–2880 CrossRef CAS .
  17. A. Kinens, M. Sejejs, A. S. Kamlet, D. W. Piotrowski, E. Vedejs and E. Suna, J. Org. Chem., 2017, 82, 869–886 CrossRef CAS PubMed .
  18. H. Mandai and S. Suga, Binaphthyl-Based Chiral DMAP Derivatives in Enantioselective Transformations, in Atropisomerism in Asymmetric Organic Synthesis, ed. S. Takizawa and M. Salem Wiley-VCH GmbH, 2024, pp. 237–266 Search PubMed .
  19. P.-L. Lagueux-Tremblay, A. Fabrikant and B. A. Arndtsen, ACS Catal., 2018, 8, 5350–5354 CrossRef CAS .
  20. T. R. Kelly and M. Cavero, Org. Lett., 2002, 4, 2653–2656 CrossRef CAS PubMed .
  21. J. Velcicky, E. Ngo, M. R. Bauer, A. Meyer, A. Schlapbach, S. Racine, D. Orain, D. Pflieger, S. Teixeira-Fouchard, C. Dubois, A. Goetz, R. Steiner, M. Palmieri, A. Bussenault, R. Stringer, P. Larger, S. Riek, P. Schmutz, S. Lehmann, C. Scheufler, J.-M. Rondeau, C. Burkhart, T. Knoepfel and N. Gommermann, ChemMedChem, 2025, 20, e202400851 CrossRef CAS PubMed .
  22. S. Sharma, N. Kanwar, A. G. H. Khan and S. Easwar, New J. Chem., 2025, 49, 4639–4646 RSC .
  23. J. W. Boyd, N. Greaves, J. Kettle, A. T. Russell and J. W. Steed, Angew. Chem., Int. Ed., 2005, 44, 944–946 CrossRef CAS PubMed .
  24. Y. Jin, P. V. Petrovic, S. Huang, S. Banerjee, A. Nandy, P. T. Anastas and J. C.-H. Lam, J. Org. Chem., 2024, 89, 3226–3237 CrossRef CAS PubMed .
  25. J. Gao, S. Bai, Q. Gao, Y. Liu and Q. Yang, Chem. Commun., 2011, 47, 6716–6718 RSC .
  26. R. Hidalgo-León, N. Alberro, F. P. Cossío, J. Miguel Sansano and M. de Gracia Retamosa, Adv. Synth. Catal., 2023, 365, 3253–3259 CrossRef .
  27. N. Diddi, L. Lai, C. H. Nguyen, D. Yan, E. Nambara and S. Abrams, Org. Biomol. Chem., 2023, 21, 3014–3019 RSC .
  28. T. Rozek, D. K. Taylor, E. R. Tiekink and J. H. Bowie, Aust. J. Chem., 1999, 52, 129–136 CrossRef CAS .
  29. M. J. Petersson, C. Marchal, W. A. Loughlin, I. D. Jenkins, P. C. Healy and A. Almesåker, Tetrahedron, 2007, 63, 1395–1401 CrossRef CAS .
  30. A. Rana, A. Mishra and S. K. Awasthi, RSC Adv., 2025, 15, 4496–4525 RSC .
  31. T. Hamada, H. Sato, M. Hikota and O. Yonemitsu, Tetrahedron Lett., 1989, 30, 6405–6408 CrossRef CAS .
  32. R. M. Vala and H. M. Patel, in Advances in Heterocyclic Chemistry, ed. E. F. V. Scriven and C. A. Ramsden, Academic Press, 2023, vol. 141, pp. 179–208 Search PubMed .
  33. T. S. Maskrey, M. C. Frischling, M. L. Rice and P. Wipf, Front. Chem., 2018, 6, 376–384 CrossRef PubMed .
  34. C. H. Escalante, E. I. Martínez-Mora, C. Espinoza-Hicks, A. A. Camacho-Dávila, F. R. Ramos-Morales, F. Delgado and J. Tamariz, Beilstein J. Org. Chem., 2020, 16, 1320–1334 CrossRef CAS PubMed .
  35. G. Frapper, C. Bachmann, Y. Gu, R. C. De Sousa and F. Jérôme, Phys. Chem. Chem. Phys., 2011, 13, 628–636 RSC .
  36. B. D. Parmar, T. R. Sutariya, G. C. Brahmbhatt, N. J. Parmar, R. Kant and V. K. Gupta, J. Org. Chem., 2016, 81, 4955–4964 CrossRef CAS PubMed .
  37. A. Ratier, R. D. Moulandou-Koumba, M. Anizan, S. Behloul, F. Guegan, G. Frapper, Q. B. Remaury, K. De Oliveira Vigier, J. Zheng and F. Jérôme, RSC Adv., 2023, 13, 30369–30377 RSC .
  38. E. Akbarzadeh, M. S. Abaee, Y. L. Nosood, M. M. Mojtahedi, K. Harms and Z. Shabani, ChemistryOpen, 2025, 14, e202500040 CrossRef PubMed .
  39. M. S. Abaee, S. Alizadeh, P. Azadi, M. M. Mojtahedi and M. R. Halvagar, ChemistrySelect, 2024, 9, e202304060 CrossRef .
  40. M. S. Abaee, M. Mohammadi, M. Mojtahedi and M. R. Halvagar, Tetrahedron Lett., 2016, 57, 4094–4097 Search PubMed .
  41. K. Erfurt, I. Wandzik, K. Walczak, K. Matuszek and A. Chrobok, Green Chem., 2014, 16, 3508–3514 RSC .
  42. A. Biswas, S. Kundu, D. Pal, A. Pal and M. S. Maji, Synthesis, 2022, 54, 887–909 CrossRef CAS .
  43. P. Forsythe, R. Frampton, C. D. Johnson and A. R. Katritzky, J. Chem. Soc. Perkin Trans., 1972, 2, 671–673 RSC .
  44. For an example of cycloaddition-aromatization sequence using DMAD or DEAD see: Y.-W. Xu, J. Wang, G. Wang and L. Zhen, J. Org. Chem., 2021, 86, 91–102 CrossRef CAS PubMed .
  45. M. S. Abaee, E. Doustkhah, M. Mohammadi, M. M. Mojtahedi and K. Harms, Can. J. Chem., 2016, 94, 733–737 CrossRef CAS .
  46. M. S. Abaee, F. Mobayen, M. M. Mojtahedi, F. Saberi and H. R. Khavasi, Arkivoc, 2015, 305–315 Search PubMed .

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.